Keywords: new, erbitux, results, add, imclone, woes, astrazeneca

New Erbitux results add to ImClone woes

Article | 27 May 2002

Print This

While AstraZeneca has much to feel positive about with its Iressa drug(see story alongside), there was worse news at ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in